Centre Mallet-Proux
- Company typePrivate
- Founded1995
- HeadquartersLaval, France
- Headcount1–10
- GTM typeB2C
- OfferingServices
Centre Mallet-Proux firmographics
Firmographics- Name
- Centre Mallet-Proux
- Legal name
- Centre Mallet Proux
- Website
- https://cmp.i-l-c.fr
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Centre Mallet-Proux industry classification
Industry- Product category
- Radiation Oncology Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Medical Laboratories (621511)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Hospitals (8060), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where Centre Mallet-Proux is headquartered
LocationHeadquarters
- HQ city
- Laval
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
Centre Mallet-Proux business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Revenue model
- Healthcare Services Revenue: Centre operates as a liberal healthcare establishment providing cancer treatment services. Services covered under French social security system (ALD 100% - Exonération du ticket modérateur for long-term illness). The centre is conventionné en secteur 1 and does not practice fee overruns.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Centre Mallet-Proux product offering
Product offeringCore offering
Centre Mallet-Proux is a private cancer treatment centre (founded 17 June 1995, part of ILC Group since 2011) that delivers external radiotherapy, chemotherapy, targeted therapies, and supportive care to adult cancer patients. Treatment is performed using modern particle accelerators (TrueBeam, Halcyon) and advanced techniques including IMRT, stereotactic radiotherapy, and 3D conformal radiotherapy, supported by a dosimetric scanner and photobiomodulation equipment.
Product overview
Centre Mallet-Proux is a specialized cancer treatment facility offering integrated oncology services including radiotherapy (using TrueBeam and Halcyon particle accelerators), chemotherapy, and targeted therapies. The center provides comprehensive care from initial consultation through treatment planning (dosimetric scanning, 3D/IMRT planning) to radiotherapy sessions and follow-up support including supportive care, psycho-oncology, and after-cancer guidance. Treatment technologies include 3D conformal radiotherapy, IMRT, and stereotactic radiotherapy, with recent addition of photobiomodulation for patient comfort.
Differentiator
Problem solved
Functional benefit
Products and services
- External Radiotherapy External beam radiation therapy delivered to cancer patients using modern linear accelerators (TrueBeam, Halcyon) and techniques including IMRT, 3D conformal radiotherapy, and stereotactic radiotherapy. Indicated for solid tumours across multiple cancer types.
- Chemotherapy Systemic anti-cancer drug therapy administered to cancer patients under oncology supervision at the centre.
- Targeted Therapies Molecularly targeted anti-cancer treatments delivered to cancer patients at the centre, complementing radiotherapy and chemotherapy.
- External Oncology Consultations Outpatient oncology consultations provided by the centre's oncologists for diagnosis, treatment planning, and follow-up of cancer patients.
- Supportive Care and Post-Cancer Follow-up Supportive care including post-cancer follow-up and related services delivered to patients during and after cancer treatment, including photobiomodulation.
Companies that use Centre Mallet-Proux
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles1 record
Centre Mallet-Proux technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Centre Mallet-Proux partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- ILC Group (Institut inter-régional de Cancérologie)coreSince 2011, Centre Mallet-Proux has been affiliated with ILC Group which operates radiotherapy and nuclear medicine centres across 4 sites (Le Mans, Chartres, Laval, Nancy). Group provides shared services including quality management, IT, HR, training, and communication support. Benefits include collaboration with physicists across all group sites for project development.
- Polyclinique du MainecoreCentre works in close collaboration with specialists at Polyclinique du Maine for supportive care including psycho-oncology, pain management, physiotherapy, nutritional support, and chemotherapy administration (day hospital and traditional hospitalization). Chemotherapy services are provided at Polyclinique du Maine facilities.
- Public Hospital Specialists (Mayenne)minorCentre collaborates with specialists from public hospitals in Mayenne department for comprehensive patient care coordination.
- Réseau de cancérologie des Pays-de-la-Loire (OncoPL)minorRegional cancer network providing guidelines and coordination for cancer treatment protocols across Pays de la Loire region.
- Ligue nationale contre le cancerminorNational cancer association providing patient support resources, information, and community connections for patients and families.
- Institut national du cancerminorFrench national cancer institute providing guidelines, standards, and research coordination for cancer treatment.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Centre Mallet-Proux competitors and assessment
Company assessmentBroad incumbents
- Institut Bergonié: Bordeaux Comprehensive Cancer Centre offering radiotherapy, chemotherapy, and surgical oncology with similar multidisciplinary governance and IMRT/stereotactic capabilities.
- Centre Antoine Lacassagne: CLCC (Centre de Lutte Contre le Cancer) in Nice operating radiotherapy and oncology services under the French UNICancer network; comparable private-non-profit cancer care model with advanced radiotherapy platforms.
- Gustave Roussy: Largest French Comprehensive Cancer Centre; comparable oncology service portfolio including advanced radiotherapy, systemic therapies, and supportive care, though operating at national-reference scale.
- Centre Léon Bérard: Lyon-based Comprehensive Cancer Centre providing radiotherapy, medical oncology, and supportive care under the same CLCC/UNICancer framework; benchmark for integrated oncology service delivery in France.
- Institut de Cancérologie de l'Ouest (ICO): Regional Comprehensive Cancer Centre covering Pays de la Loire and Bretagne with radiotherapy, chemotherapy, and surgical oncology; overlaps Centre Mallet-Proux's catchment and serves as the main academic/tertiary alternative.
Direct peers
- Oncorad (Groupe Oncorad): Private radiotherapy group operating multiple centres across France with comparable linear-accelerator technology and outpatient oncology positioning; competing for the same liberal-sector radiotherapy demand.
- COREL (Centre d'Oncologie et de Radiothérapie): Another ILC Group radiotherapy site sharing identical operational model, equipment philosophy, and RCP-integrated multidisciplinary approach; the closest internal benchmark for Centre Mallet-Proux.
- Centre Jean Bernard: Sibling ILC Group radiotherapy centre in Le Mans offering the same particle-accelerator-based cancer care model; directly comparable in scope, technology stack, and patient pathway.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Centre Mallet-Proux social profiles
Digital presenceCentre Mallet-Proux compliance and trust
Trust signalCompliance2 records
Centre Mallet-Proux financial estimates
Financial estimateRevenue estimate
Valuation estimate
Centre Mallet-Proux leadership team
Management profileNumber of profiles
Profiles3 records
Centre Mallet-Proux funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Centre Mallet-Proux M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Centre Mallet-Proux
What does Centre Mallet-Proux do?
Centre Mallet-Proux is a private cancer treatment centre (founded 17 June 1995, part of ILC Group since 2011) that delivers external radiotherapy, chemotherapy, targeted therapies, and supportive care to adult cancer patients. Treatment is performed using modern particle accelerators (TrueBeam, Halcyon) and advanced techniques including IMRT, stereotactic radiotherapy, and 3D conformal radiotherapy, supported by a dosimetric scanner and photobiomodulation equipment.
Is Centre Mallet-Proux a public or private company?
Centre Mallet-Proux is a private company. It is classified as corporate owned and is currently operating.
When was Centre Mallet-Proux founded?
Centre Mallet-Proux was founded in 1995. It employs 1 to 10 people.
Where is Centre Mallet-Proux based?
Centre Mallet-Proux is headquartered in Laval, France, in the Europe region.
How does Centre Mallet-Proux make money?
One revenue line is on record: healthcare Services Revenue.
Who are Centre Mallet-Proux's main competitors?
Broad incumbents on record are Institut Bergonié, Centre Antoine Lacassagne, Gustave Roussy, Centre Léon Bérard and Institut de Cancérologie de l'Ouest (ICO). Direct peers are Oncorad (Groupe Oncorad), COREL (Centre d'Oncologie et de Radiothérapie) and Centre Jean Bernard.
Does Centre Mallet-Proux have an API?
No public API is recorded for Centre Mallet-Proux.
What industry is Centre Mallet-Proux in?
Centre Mallet-Proux's product category is Radiation Oncology Services. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 622310 and its SIC code is 8011.